ESSA Pharma Inc. EPIX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • CA • USD

SharesGrow Score

58/100

3/6 Pass

SharesGrow Intrinsic Value

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

ESSA Pharma Inc. (EPIX) .

本页证实的标准:

VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+4621.7%).
分析师共识目标价 $9.50 (+4621.7% 上行空间) — 华尔街分析师认为存在显著上行潜力。

SharesGrow 综合评分： 56/100 其中 3/7 项标准通过。

SharesGrow 7-Criteria Score

58/100

SG Score

View full scorecard →

✓

价值

100/100

Price-to-Earnings & upside

Proven by this page

未來

52/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✓

健康

100/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

28/100

→ Income

✓

成长

65/100

→ Income

—

收入

N/A

No coverage

估值概览 — EPIX

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.64

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

分析师目标价$9.50 (+4621.7%)

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2015	$-9.34	$0.00	$-8.57M	-
2016	$-9.77	$217.00	$-13.14M	-6055299.5%
2017	$-3.09	$0.00	$-4.5M	-
2018	$-2.55	$0.00	$-11.63M	-
2019	$-1.24	$0.00	$-10.44M	-
2020	$-1.04	$0.00	$-23.45M	-
2021	$-0.96	$0.00	$-36.81M	-
2022	$-0.80	$0.00	$-35.1M	-
2023	$-0.60	$0.00	$-26.58M	-
2024	$-0.64	$0.00	$-28.54M	-